{"id":344522,"date":"2026-11-12T10:31:32","date_gmt":"2026-11-12T05:01:32","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=344522"},"modified":"2026-11-12T10:31:32","modified_gmt":"2026-11-12T05:01:32","slug":"power-generation-and-distribution-company-software-product-engineering-company-and-pharmaceutical-company-stocks-roadmap-vantage-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/power-generation-and-distribution-company-software-product-engineering-company-and-pharmaceutical-company-stocks-roadmap-vantage-list\/","title":{"rendered":"3 Power Generation and Distribution Company, Software Product Engineering Company and Pharmaceutical Company Stocks With a Strong Future Roadmap: Torrent Power, Persistent Systems and Eris Lifesciences"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E84;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Torrent Power, Persistent Systems and Eris Lifesciences: ROE of 12.7% to 21.0% and FY22 to FY26 revenue CAGR of 19.2% to 26.4%. Prices as of 11 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E84;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The three power distribution, IT product and pharma stocks to watch are Torrent Power, Persistent Systems and Eris Lifesciences. Their return on equity ranges from 12.7% to 21.0%, and their revenue compound annual growth from FY22 to FY26 ranges from 19.2% to 26.4%. Persistent Systems leads on both return on equity at 21.0% and revenue growth at 26.4% a year. Prices are based on the 11 November 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n<p>Power distribution, IT product and pharma stocks bring together companies with a visible plan for the years ahead. Torrent Power, Persistent Systems and Eris Lifesciences cover a power generation and distribution company, a software product engineering company and a pharmaceutical company.<\/p>\n<p>This list covers three power distribution, IT product and pharma stocks with complete current figures: Torrent Power, Persistent Systems and Eris Lifesciences. Every figure comes from the latest reported financials and the 11 November 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=power-generation-and-distribution-company-software-product-engineering-company-and-pharmaceutical-company-stocks-roadmap-vantage-list\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/power-generation-and-distribution-company-software-product-engineering-company-and-pharmaceutical-company-stocks-roadmap-vantage-list\/#What_Are_Power_Distribution_IT_Product_and_Pharma_Stocks\" title=\"What Are Power Distribution, IT Product and Pharma Stocks?\">What Are Power Distribution, IT Product and Pharma Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/power-generation-and-distribution-company-software-product-engineering-company-and-pharmaceutical-company-stocks-roadmap-vantage-list\/#Power_Distribution_IT_Product_and_Pharma_Stocks_at_a_Glance\" title=\"Power Distribution, IT Product and Pharma Stocks at a Glance\">Power Distribution, IT Product and Pharma Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/power-generation-and-distribution-company-software-product-engineering-company-and-pharmaceutical-company-stocks-roadmap-vantage-list\/#Why_Do_Power_Distribution_IT_Product_and_Pharma_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Power Distribution, IT Product and Pharma Stocks Have a Strong Roadmap in India?\">Why Do Power Distribution, IT Product and Pharma Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/power-generation-and-distribution-company-software-product-engineering-company-and-pharmaceutical-company-stocks-roadmap-vantage-list\/#Why_Torrent_Power_Features_Among_These_Power_Distribution_IT_Product_and_Pharma_Stocks\" title=\"Why Torrent Power Features Among These Power Distribution, IT Product and Pharma Stocks\">Why Torrent Power Features Among These Power Distribution, IT Product and Pharma Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/power-generation-and-distribution-company-software-product-engineering-company-and-pharmaceutical-company-stocks-roadmap-vantage-list\/#Why_Persistent_Systems_Features_Among_These_Power_Distribution_IT_Product_and_Pharma_Stocks\" title=\"Why Persistent Systems Features Among These Power Distribution, IT Product and Pharma Stocks\">Why Persistent Systems Features Among These Power Distribution, IT Product and Pharma Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/power-generation-and-distribution-company-software-product-engineering-company-and-pharmaceutical-company-stocks-roadmap-vantage-list\/#Why_Eris_Lifesciences_Features_Among_These_Power_Distribution_IT_Product_and_Pharma_Stocks\" title=\"Why Eris Lifesciences Features Among These Power Distribution, IT Product and Pharma Stocks\">Why Eris Lifesciences Features Among These Power Distribution, IT Product and Pharma Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/power-generation-and-distribution-company-software-product-engineering-company-and-pharmaceutical-company-stocks-roadmap-vantage-list\/#Torrent_Power_vs_Persistent_Systems_vs_Eris_Lifesciences_on_Key_Financials\" title=\"Torrent Power vs Persistent Systems vs Eris Lifesciences on Key Financials\">Torrent Power vs Persistent Systems vs Eris Lifesciences on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/power-generation-and-distribution-company-software-product-engineering-company-and-pharmaceutical-company-stocks-roadmap-vantage-list\/#Key_Risks_to_Check_Before_Investing_in_Power_Distribution_IT_Product_and_Pharma_Stocks\" title=\"Key Risks to Check Before Investing in Power Distribution, IT Product and Pharma Stocks\">Key Risks to Check Before Investing in Power Distribution, IT Product and Pharma Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/power-generation-and-distribution-company-software-product-engineering-company-and-pharmaceutical-company-stocks-roadmap-vantage-list\/#Final_Thoughts_on_Power_Distribution_IT_Product_and_Pharma_Stocks\" title=\"Final Thoughts on Power Distribution, IT Product and Pharma Stocks\">Final Thoughts on Power Distribution, IT Product and Pharma Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/power-generation-and-distribution-company-software-product-engineering-company-and-pharmaceutical-company-stocks-roadmap-vantage-list\/#What_are_power_distribution_IT_product_and_pharma_stocks\" title=\"What are power distribution, IT product and pharma stocks?\">What are power distribution, IT product and pharma stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/power-generation-and-distribution-company-software-product-engineering-company-and-pharmaceutical-company-stocks-roadmap-vantage-list\/#Which_power_distribution_IT_product_and_pharma_stocks_are_covered_in_this_list\" title=\"Which power distribution, IT product and pharma stocks are covered in this list?\">Which power distribution, IT product and pharma stocks are covered in this list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/power-generation-and-distribution-company-software-product-engineering-company-and-pharmaceutical-company-stocks-roadmap-vantage-list\/#Why_do_power_distribution_IT_product_and_pharma_stocks_have_a_strong_future_roadmap_in_India\" title=\"Why do power distribution, IT product and pharma stocks have a strong future roadmap in India?\">Why do power distribution, IT product and pharma stocks have a strong future roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/power-generation-and-distribution-company-software-product-engineering-company-and-pharmaceutical-company-stocks-roadmap-vantage-list\/#How_has_Torrent_Power_performed_financially\" title=\"How has Torrent Power performed financially?\">How has Torrent Power performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/power-generation-and-distribution-company-software-product-engineering-company-and-pharmaceutical-company-stocks-roadmap-vantage-list\/#How_has_Persistent_Systems_performed_financially\" title=\"How has Persistent Systems performed financially?\">How has Persistent Systems performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/power-generation-and-distribution-company-software-product-engineering-company-and-pharmaceutical-company-stocks-roadmap-vantage-list\/#How_has_Eris_Lifesciences_performed_financially\" title=\"How has Eris Lifesciences performed financially?\">How has Eris Lifesciences performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/power-generation-and-distribution-company-software-product-engineering-company-and-pharmaceutical-company-stocks-roadmap-vantage-list\/#What_risks_should_investors_check_before_buying_power_distribution_IT_product_and_pharma_stocks\" title=\"What risks should investors check before buying power distribution, IT product and pharma stocks?\">What risks should investors check before buying power distribution, IT product and pharma stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/power-generation-and-distribution-company-software-product-engineering-company-and-pharmaceutical-company-stocks-roadmap-vantage-list\/#Is_this_list_of_power_distribution_IT_product_and_pharma_stocks_investment_advice\" title=\"Is this list of power distribution, IT product and pharma stocks investment advice?\">Is this list of power distribution, IT product and pharma stocks investment advice?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Power_Distribution_IT_Product_and_Pharma_Stocks\"><\/span><strong>What Are Power Distribution, IT Product and Pharma Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Power distribution, IT product and pharma stocks are listed companies that generate and distribute electricity to cities and industry, build software products and digital engineering for global clients, and develop and sell medicines for chronic and lifestyle conditions. Their earnings depend on power demand, client technology budgets and prescription demand.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Power_Distribution_IT_Product_and_Pharma_Stocks_at_a_Glance\"><\/span><strong>Power Distribution, IT Product and Pharma Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE (%)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">D\/E<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/torntpower\/torrent-power-ltd-share-price-today\">Torrent Power<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,236.4<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">60,947<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">25.5<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">21.8<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12.7<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.73<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/persistent\/persistent-systems-ltd-share-price-today\">Persistent Systems<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,973.5<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">90,857<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">50.4<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">21.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.07<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/eris\/eris-lifesciences-ltd-share-price-today\">Eris Lifesciences<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,275.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15,618<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">23.5<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.60<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>On valuation, Eris Lifesciences trades at a P\/E below the industry P\/E, while Torrent Power and Persistent Systems trade above it, which reflects the growth the market already expects. Readers comparing power distribution, IT product and pharma stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Power_Distribution_IT_Product_and_Pharma_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Power Distribution, IT Product and Pharma Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Power distribution, IT product and pharma stocks have a strong roadmap in India because rising electricity use, growing product engineering work and steady demand for chronic care medicines keep widening the market for these companies.<\/p>\n<ul>\n<li><strong>Power distribution.<\/strong> Cities and factories use more electricity.<\/li>\n<li><strong>Product engineering.<\/strong> Global firms outsource software building.<\/li>\n<li><strong>Pharma.<\/strong> Doctors prescribe branded medicines widely.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Why_Torrent_Power_Features_Among_These_Power_Distribution_IT_Product_and_Pharma_Stocks\"><\/span><strong>Why Torrent Power Features Among These Power Distribution, IT Product and Pharma Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the power distribution, IT product and pharma stocks on this list, Torrent Power is an integrated power company in Gujarat that generates, transmits and distributes electricity, with operations in Ahmedabad, Surat and Bhiwandi, and a growing renewable energy portfolio.<\/p>\n<p>The company has a return on equity of 12.7%, a debt to equity ratio of 0.73 and a market capitalisation of Rs 60,947 crore. The stock trades at a P\/E of 25.5, above the industry P\/E of 21.8.<\/p>\n<p>Revenue rose from Rs 14,493 crore in FY22 to Rs 29,289 crore in FY26, a compound annual growth rate of 19.2%. Net profit grew from Rs 459 crore in FY22 to Rs 2,469 crore in FY26, which works out to a compound annual growth rate of 52.3%. In the June 2026 quarter, revenue grew 2.4% year on year to Rs 8,205 crore.<\/p>\n<p><strong>Roadmap:<\/strong> The company operates a stable distribution franchise and is adding large renewable capacity alongside new thermal and pumped storage projects. Its distribution licences in major cities provide steady cash flows that support these investments.<\/p>\n<p><strong>What to watch:<\/strong> Monitor renewable capacity commissioning and the progress of new generation projects.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Persistent_Systems_Features_Among_These_Power_Distribution_IT_Product_and_Pharma_Stocks\"><\/span><strong>Why Persistent Systems Features Among These Power Distribution, IT Product and Pharma Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the electricity, software engineering and branded medicine shares on this list, Persistent Systems is a Pune-based technology services and digital engineering company that builds software products and platforms for clients in banking, healthcare, software and hi-tech industries worldwide.<\/p>\n<p>Revenue rose from Rs 5,855 crore in FY22 to Rs 14,929 crore in FY26, a compound annual growth rate of 26.4%. Net profit grew from Rs 690 crore in FY22 to Rs 1,865 crore in FY26, which works out to a compound annual growth rate of 28.2%.<\/p>\n<p>The company has a return on equity of 21.0%, a debt to equity ratio of 0.07 and a market capitalisation of Rs 90,857 crore. The stock trades at a P\/E of 50.4, above the industry P\/E of 17.9.<\/p>\n<p><strong>Roadmap:<\/strong> The company is deepening its work in cloud, data and artificial intelligence, where enterprises are raising spending. A strong base of long-term clients helps it win larger engineering programmes.<\/p>\n<p><strong>What to watch:<\/strong> Track large deal wins, client additions and the share of artificial intelligence work in revenue.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Eris_Lifesciences_Features_Among_These_Power_Distribution_IT_Product_and_Pharma_Stocks\"><\/span><strong>Why Eris Lifesciences Features Among These Power Distribution, IT Product and Pharma Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the three companies on this list, Eris Lifesciences is an Indian pharmaceutical company with branded formulations in chronic therapies such as cardiac, diabetes and gastro-intestinal care, along with an injectables business.<\/p>\n<p>In the June 2026 quarter, revenue grew 12.9% year on year to Rs 876 crore, while net profit rose 14.6% to Rs 143 crore. Revenue rose from Rs 1,373 crore in FY22 to Rs 3,137 crore in FY26, a compound annual growth rate of 22.9%.<\/p>\n<p>Net profit grew from Rs 406 crore in FY22 to Rs 648 crore in FY26, which works out to a compound annual growth rate of 12.4%. The company has a return on equity of 15.9%, a debt to equity ratio of 0.60 and a market capitalisation of Rs 15,618 crore. The stock trades at a P\/E of 23.5, below the industry P\/E of 36.0.<\/p>\n<p><strong>Roadmap:<\/strong> Its portfolio expansion, including the addition of branded domestic formulations from other companies and its injectables unit, widens its reach with doctors. Chronic therapy brands bring repeat prescriptions, which supports steady revenue.<\/p>\n<p><strong>What to watch:<\/strong> Check how smoothly acquired brands are integrated and how the injectables unit scales.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Torrent_Power_vs_Persistent_Systems_vs_Eris_Lifesciences_on_Key_Financials\"><\/span><strong>Torrent Power vs Persistent Systems vs Eris Lifesciences on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets the three power distribution, IT product and pharma stocks side by side on revenue, profit and margin, using reported figures.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY22 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Revenue CAGR (FY22-FY26)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Torrent Power<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">14,493<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">29,289<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">19.2%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,469<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">8.4%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Persistent Systems<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,855<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">14,929<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">26.4%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,865<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12.5%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Eris Lifesciences<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,373<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,137<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">22.9%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">648<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">20.6%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Persistent Systems posts the highest return on equity in this group at 21.0%. Torrent Power has the largest FY26 revenue at Rs 29,289 crore, and Persistent Systems shows the fastest revenue growth with a 26.4% compound annual rate. A useful habit with power distribution, IT product and pharma stocks is to check each new quarterly result against the capacity plans the company described earlier.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Check_Before_Investing_in_Power_Distribution_IT_Product_and_Pharma_Stocks\"><\/span><strong>Key Risks to Check Before Investing in Power Distribution, IT Product and Pharma Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Every theme carries risks that deserve a check before any decision. For these power distribution, IT product and pharma stocks, the main points are: Long-term electricity, software engineering and branded medicine shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.<\/p>\n<ul>\n<li><strong>Fuel and power prices.<\/strong> Tariffs and fuel costs can influence earnings.<\/li>\n<li><strong>Client spending.<\/strong> Technology budgets can vary with global conditions.<\/li>\n<li><strong>Pricing pressure.<\/strong> Generic prices can change by market.<\/li>\n<\/ul>\n<p>Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Use the Univest Stock Screener<\/a><\/strong> to filter power distribution, IT product and pharma stocks by market capitalisation, P\/E, ROE and growth, and build your own shortlist.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Thoughts_on_Power_Distribution_IT_Product_and_Pharma_Stocks\"><\/span><strong>Final Thoughts on Power Distribution, IT Product and Pharma Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Power distribution, IT product and pharma stocks suit investors who prefer to study business strength before price moves. Torrent Power, Persistent Systems and Eris Lifesciences each have a clear plan to grow. Based on the 11 November 2026 close, Torrent Power trades at Rs 1,236.4, Persistent Systems at Rs 5,973.5 and Eris Lifesciences at Rs 1,275.1.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track power distribution, IT product and pharma stocks, set price alerts and get research-backed stock ideas.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_are_power_distribution_IT_product_and_pharma_stocks\"><\/span><strong>What are power distribution, IT product and pharma stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Power distribution, IT product and pharma stocks are listed companies that generate and distribute electricity to cities and industry, build software products and digital engineering for global clients, and develop and sell medicines for chronic and lifestyle conditions. Their earnings depend on power demand, client technology budgets and prescription demand. This list looks at three of them, Torrent Power, Persistent Systems and Eris Lifesciences, using reported FY22 to FY26 financials and the 11 November 2026 closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_power_distribution_IT_product_and_pharma_stocks_are_covered_in_this_list\"><\/span><strong>Which power distribution, IT product and pharma stocks are covered in this list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This list covers Torrent Power, Persistent Systems and Eris Lifesciences. Based on the 11 November 2026 close, Torrent Power traded at Rs 1,236.4, Persistent Systems at Rs 5,973.5 and Eris Lifesciences at Rs 1,275.1. Their return on equity ranges from 12.7% to 21.0%, and their revenue compound annual growth from FY22 to FY26 ranges from 19.2% to 26.4%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_do_power_distribution_IT_product_and_pharma_stocks_have_a_strong_future_roadmap_in_India\"><\/span><strong>Why do power distribution, IT product and pharma stocks have a strong future roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Power distribution, IT product and pharma stocks have a strong roadmap in India because rising electricity use, growing product engineering work and steady demand for chronic care medicines keep widening the market for these companies. The main drivers are as follows. Power distribution. Cities and factories use more electricity. Product engineering. Global firms outsource software building. Pharma. Doctors prescribe branded medicines widely. Together these factors give the companies on this list a visible path for growth over the coming years.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Torrent_Power_performed_financially\"><\/span><strong>How has Torrent Power performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 14,493 crore in FY22 to Rs 29,289 crore in FY26, a compound annual growth rate of 19.2%. Net profit grew from Rs 459 crore in FY22 to Rs 2,469 crore in FY26, which works out to a compound annual growth rate of 52.3%. In the June 2026 quarter, revenue grew 2.4% year on year to Rs 8,205 crore. The company has a return on equity of 12.7%, a debt to equity ratio of 0.73 and a market capitalisation of Rs 60,947 crore. The stock trades at a P\/E of 25.5, above the industry P\/E of 21.8. Looking ahead, the company operates a stable distribution franchise and is adding large renewable capacity alongside new thermal and pumped storage projects. Its distribution licences in major cities provide steady cash flows that support these investments.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Persistent_Systems_performed_financially\"><\/span><strong>How has Persistent Systems performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 5,855 crore in FY22 to Rs 14,929 crore in FY26, a compound annual growth rate of 26.4%. Net profit grew from Rs 690 crore in FY22 to Rs 1,865 crore in FY26, which works out to a compound annual growth rate of 28.2%. The company has a return on equity of 21.0%, a debt to equity ratio of 0.07 and a market capitalisation of Rs 90,857 crore. The stock trades at a P\/E of 50.4, above the industry P\/E of 17.9. Looking ahead, the company is deepening its work in cloud, data and artificial intelligence, where enterprises are raising spending. A strong base of long-term clients helps it win larger engineering programmes.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Eris_Lifesciences_performed_financially\"><\/span><strong>How has Eris Lifesciences performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 1,373 crore in FY22 to Rs 3,137 crore in FY26, a compound annual growth rate of 22.9%. Net profit grew from Rs 406 crore in FY22 to Rs 648 crore in FY26, which works out to a compound annual growth rate of 12.4%. In the June 2026 quarter, revenue grew 12.9% year on year to Rs 876 crore, while net profit rose 14.6% to Rs 143 crore. The company has a return on equity of 15.9%, a debt to equity ratio of 0.60 and a market capitalisation of Rs 15,618 crore. The stock trades at a P\/E of 23.5, below the industry P\/E of 36.0. Looking ahead, its portfolio expansion, including the addition of branded domestic formulations from other companies and its injectables unit, widens its reach with doctors. Chronic therapy brands bring repeat prescriptions, which supports steady revenue.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_should_investors_check_before_buying_power_distribution_IT_product_and_pharma_stocks\"><\/span><strong>What risks should investors check before buying power distribution, IT product and pharma stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should check a few risks before buying power distribution, IT product and pharma stocks. Fuel and power prices. Tariffs and fuel costs can influence earnings. Client spending. Technology budgets can vary with global conditions. Pricing pressure. Generic prices can change by market. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_list_of_power_distribution_IT_product_and_pharma_stocks_investment_advice\"><\/span><strong>Is this list of power distribution, IT product and pharma stocks investment advice?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. This article is educational and uses publicly available data as of the 11 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are power distribution, IT product and pharma stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Power distribution, IT product and pharma stocks are listed companies that generate and distribute electricity to cities and industry, build software products and digital engineering for global clients, and develop and sell medicines for chronic and lifestyle conditions. Their earnings depend on power demand, client technology budgets and prescription demand. This list looks at three of them, Torrent Power, Persistent Systems and Eris Lifesciences, using reported FY22 to FY26 financials and the 11 November 2026 closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Which power distribution, IT product and pharma stocks are covered in this list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This list covers Torrent Power, Persistent Systems and Eris Lifesciences. Based on the 11 November 2026 close, Torrent Power traded at Rs 1,236.4, Persistent Systems at Rs 5,973.5 and Eris Lifesciences at Rs 1,275.1. Their return on equity ranges from 12.7% to 21.0%, and their revenue compound annual growth from FY22 to FY26 ranges from 19.2% to 26.4%.\"}},{\"@type\":\"Question\",\"name\":\"Why do power distribution, IT product and pharma stocks have a strong future roadmap in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Power distribution, IT product and pharma stocks have a strong roadmap in India because rising electricity use, growing product engineering work and steady demand for chronic care medicines keep widening the market for these companies. The main drivers are as follows. Power distribution. Cities and factories use more electricity. Product engineering. Global firms outsource software building. Pharma. Doctors prescribe branded medicines widely. Together these factors give the companies on this list a visible path for growth over the coming years.\"}},{\"@type\":\"Question\",\"name\":\"How has Torrent Power performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 14,493 crore in FY22 to Rs 29,289 crore in FY26, a compound annual growth rate of 19.2%. Net profit grew from Rs 459 crore in FY22 to Rs 2,469 crore in FY26, which works out to a compound annual growth rate of 52.3%. In the June 2026 quarter, revenue grew 2.4% year on year to Rs 8,205 crore. The company has a return on equity of 12.7%, a debt to equity ratio of 0.73 and a market capitalisation of Rs 60,947 crore. The stock trades at a P\/E of 25.5, above the industry P\/E of 21.8. Looking ahead, the company operates a stable distribution franchise and is adding large renewable capacity alongside new thermal and pumped storage projects. Its distribution licences in major cities provide steady cash flows that support these investments.\"}},{\"@type\":\"Question\",\"name\":\"How has Persistent Systems performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 5,855 crore in FY22 to Rs 14,929 crore in FY26, a compound annual growth rate of 26.4%. Net profit grew from Rs 690 crore in FY22 to Rs 1,865 crore in FY26, which works out to a compound annual growth rate of 28.2%. The company has a return on equity of 21.0%, a debt to equity ratio of 0.07 and a market capitalisation of Rs 90,857 crore. The stock trades at a P\/E of 50.4, above the industry P\/E of 17.9. Looking ahead, the company is deepening its work in cloud, data and artificial intelligence, where enterprises are raising spending. A strong base of long-term clients helps it win larger engineering programmes.\"}},{\"@type\":\"Question\",\"name\":\"How has Eris Lifesciences performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 1,373 crore in FY22 to Rs 3,137 crore in FY26, a compound annual growth rate of 22.9%. Net profit grew from Rs 406 crore in FY22 to Rs 648 crore in FY26, which works out to a compound annual growth rate of 12.4%. In the June 2026 quarter, revenue grew 12.9% year on year to Rs 876 crore, while net profit rose 14.6% to Rs 143 crore. The company has a return on equity of 15.9%, a debt to equity ratio of 0.60 and a market capitalisation of Rs 15,618 crore. The stock trades at a P\/E of 23.5, below the industry P\/E of 36.0. Looking ahead, its portfolio expansion, including the addition of branded domestic formulations from other companies and its injectables unit, widens its reach with doctors. Chronic therapy brands bring repeat prescriptions, which supports steady revenue.\"}},{\"@type\":\"Question\",\"name\":\"What risks should investors check before buying power distribution, IT product and pharma stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should check a few risks before buying power distribution, IT product and pharma stocks. Fuel and power prices. Tariffs and fuel costs can influence earnings. Client spending. Technology budgets can vary with global conditions. Pricing pressure. Generic prices can change by market. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.\"}},{\"@type\":\"Question\",\"name\":\"Is this list of power distribution, IT product and pharma stocks investment advice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. This article is educational and uses publicly available data as of the 11 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Power Distribution, IT Product and Pharma Stocks with a strong future roadmap: Torrent Power, Persistent Systems and Eris Lifesciences. Compare price, valuation, return on equity and revenue growth as of 11 November 2026.<\/p>\n","protected":false},"author":29,"featured_media":344521,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[3803,19794,13903,22528,1223,22527,13455,22530,22529,7782],"class_list":["post-344522","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-best-stocks","tag-electricity","tag-eris-lifesciences","tag-it-product-and-pharma-stocks","tag-persistent-systems","tag-power-distribution","tag-power-utility","tag-product-engineering-and-chronic-care-drug-stocks","tag-software-engineering-and-branded-medicine-shares","tag-torrent-power"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["344521"],"rank_math_title":["Power Distribution, IT Product and Pharma Stocks"],"rank_math_description":["Compare 3 power distribution, IT product and pharma stocks with a strong future roadmap on CMP, market cap, P\/E, ROE and revenue growth. Data as of 11 Nov 2026."],"rank_math_focus_keyword":["power distribution, IT product and pharma stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/3-power-generation-and-distribution-company-software-product-engineering-company.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/344522","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=344522"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/344522\/revisions"}],"predecessor-version":[{"id":344523,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/344522\/revisions\/344523"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/344521"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=344522"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=344522"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=344522"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}